Publications & Posters
Scholarly publications
Facioscapulohumeral Muscular Dystrophy
Apitegromab
June 2026
2026 International Research Congress on FSHD
Trial design for the Phase 2 FORGE study evaluating apitegromab in adults with facioscapulohumeral muscular dystrophy
Spinal Muscular Atrophy
Apitegromab
June 2026
2026 Annual SMA Research and Clinical Care Meeting
Post hoc analyses from the Phase 3 SAPPHIRE study evaluating apitegromab in patients with nonambulatory type 2 or 3 spinal muscular atrophy
Spinal Muscular Atrophy
Apitegromab
June 2026
2026 Annual SMA Research and Clinical Care Meeting
Impact of baseline characteristics on apitegromab efficacy in patients with spinal muscular atrophy
Spinal Muscular Atrophy
Apitegromab
June 2026
2026 Annual SMA Research and Clinical Care Meeting
Assessing the impact of ‘any point differences’ or ‘stability’ in the Hammersmith Functional Motor Scale-Expanded on the independence of patients with SMA
Cardiometabolic Disease
June 2026
American Diabetes Association 2026 Scientific Sessions
A novel anti-myostatin GLP-1RA fusion molecule to preserve muscle and improve body composition during GLP-1 RA therapy
Cardiometabolic Disease
May 2026
The Essential Protein & Antibody Engineering Summit
